TABLE 3.

Overall summary of adverse events by category^a

Adverse event category	Linezolid- treated patients (n = 2,046)		Comparator- treated patients (n = 2,001)		P value
	No.	%	No.	%
Adverse events
Patients with one or more AEs	1,137	55.6	988	49.4	0.001
Drug discontinued due to AEs	118	5.8	105	5.2	0.489
Drug-related adverse events
Patients with one or more DRAEs	444	21.7	314	15.7	0.001
Drug discontinued due to DRAEs	50	2.4	38	1.9	0.230
Serious adverse events
Patients with one or more SAEs	233	11.4	212	10.6	0.568
Patients who died	98	4.8	99	4.9	0.596

^aAbbreviations: AEs, adverse events; DRAEs, drug-related adverse events; SAEs, serious adverse events.